Myosteatosis predicts postoperative complications and long‐term survival in robotic gastrectomy for gastric cancer: A propensity score analysis
European Journal of Clinical Investigation · 2024
DOI: 10.1111/eci.14201 ↗At a glance
Journal article in European Journal of Clinical Investigation, 2024. Written by Pingan Ding and 10 co-authors. Institution: The Third Department of Surgery, the Fourth Hospital of Hebei Medical University, Shijiazhuang, China. Major MEDLINE topics: Stomach Neoplasms, Gastrectomy, Propensity Score, Postoperative Complications. Cited 8 times so far (Crossref); 40 references.
Abstract (original language)
Background
Robotic gastrectomy is increasingly utilized for gastric cancer, but high morbidity remains a concern. Myosteatosis or low skeletal muscle density reflecting fatty infiltration, associates with complications after other cancer surgeries but has not been evaluated for robotic gastrectomy.
Methods
This retrospective study analysed 381 patients undergoing robotic gastrectomy for gastric cancer from September 2019 to October 2022. Myosteatosis was quantified on preoperative computed tomography (CT) images at lumbar 3 (L3). Propensity score matching addressed potential confounding between myosteatosis and non‐myosteatosis groups. Outcomes were postoperative complications, 30 days mortality, 30 days readmissions and survival.
Results
Myosteatosis was present in 33.6% of patients. Myosteatosis associated with increased overall (47.7% vs. 26.5%, p < 0.001) and severe complications (12.4% vs. 4.9%, p < 0.001). After matching, myosteatosis remained associated with increased overall complications, major complications, intensive care unit (ICU) transfer and readmission (all p < 0.05). Myosteatosis independently predicted overall [odds ratio (OR) = 2.86, 95% confidence interval (CI): 1.57–5.20, p = 0.001] and severe complications (OR = 4.81, 95% CI: 1.51–15.27, p = 0.008). Myosteatosis also associated with reduced overall (85.0% vs. 93.2%, p = 0.015) and disease‐free survival (80.3% vs. 88.4%, p= 0.029). On multivariate analysis, myosteatosis independently predicted poorer survival [hazard ratio (HR) = 2.83, 95% CI: 1.32–6.08, p= 0.012] and disease‐free survival (HR = 1.83, 95% CI: 1.01–3.30, p= 0.032).
Conclusion
Preoperative CT‐defined myosteatosis independently predicts increased postoperative complications and reduced long‐term survival after robotic gastrectomy for gastric cancer. Assessing myosteatosis on staging CT could optimize preoperative risk stratification.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- The Third Department of Surgery, the Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
- Hebei Key Laboratory of Precision Diagnosis and Comprehensive Treatment of Gastric Cancer, Shijiazhuang, China.
- Big data analysis and mining application for precise diagnosis and treatment of gastric cancer Hebei Provincial Engineering Research Center, Shijiazhuang, China.
- The Department of CT/MRI, the Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
- Research Center of the Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
ORCID profiles: Qun Zhao
Cite
APA
Ding, P., Wu, J., Wu, H., Li, T., Yang, J., Yang, L., Guo, H., Tian, Y., Yang, P., Meng, L., & Zhao, Q. (2024). Myosteatosis predicts postoperative complications and long‐term survival in robotic gastrectomy for gastric cancer: A propensity score analysis. European Journal of Clinical Investigation. https://doi.org/10.1111/eci.14201
Vancouver
Ding P, Wu J, Wu H, Li T, Yang J, Yang L, et al. Myosteatosis predicts postoperative complications and long‐term survival in robotic gastrectomy for gastric cancer: A propensity score analysis. European Journal of Clinical Investigation. 2024. doi:10.1111/eci.14201
BibTeX
@article{Ding2024,
author = {Ding, Pingan and Wu, Jiaxiang and Wu, Haotian and Li, Tongkun and Yang, Jiaxuan and Yang, Li and Guo, Honghai and Tian, Yuan and Yang, Peigang and Meng, Lingjiao and Zhao, Qun},
title = {Myosteatosis predicts postoperative complications and long‐term survival in robotic gastrectomy for gastric cancer: A propensity score analysis},
journal = {European Journal of Clinical Investigation},
year = {2024},
doi = {10.1111/eci.14201}
}
EUVIMED